The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review
- 11 May 2024
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 23 (3) , 393-398
Abstract
A 73-year-old Japanese man with a history of distal biliary cancer treated by pancreatoduodenectomy developed pancreatic acinar cell carcinoma (PACC) treated by remnant pancreatectomy and adjuvant chemotherapy. Thirteen months after surgery, multiple liver metastases developed and FOLFOX chemotherapy was initiated. Based on the PACC diagnosis and a positive family history for breast and ovarian cancer genetic testing was performed which revealed a pathogenic germline BRCA2 variant (c.8629G > T, p.Glu2877Ter). Olaparib therapy was initiated and the metastases responded well (partial response). PACC is a BRCA2-associated cancer which may respond well to PARP inhibitors.Keywords
Funding Information
- JSPS KAKENHI (19K19372)
This publication has 23 references indexed in Scilit:
- Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic VariantsJAMA Oncology, 2022
- Pancreatic Acinar Cell Carcinoma with Germline BRCA2 Mutation and Severe Pancreatic Panniculitis: A Case ReportVisceral Medicine, 2021
- Multicenter Retrospective Analysis of Chemotherapy for Advanced Pancreatic Acinar Cell CarcinomaPancreas, 2021
- Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genesEBioMedicine, 2020
- Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic CancerNew England Journal of Medicine, 2019
- Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparibMedicine, 2018
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationNew England Journal of Medicine, 2017
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian CancerNew England Journal of Medicine, 2016
- Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreasScientific Reports, 2015
- Pathology and genetics of pancreatic neoplasms with acinar differentiationSeminars in Diagnostic Pathology, 2014